Evidence map›Paper›PMID 37352927›Full record

ArticleClinics and research in hepatology and gastroenterology2023

Early life exposures as risk factors for non-esophageal eosinophilic gastrointestinal diseases.

Elizabeth T Jensen, Xiangfeng Dai, Ellyn Kodroff, Mary Jo Strobel, Amy Zicarelli, Sarah Gray, Amanda Cordell, Chelsea Anderson, Girish Hiremath, Evan S Dellon

Open access · greenAbstract read
In one paragraph

Article in Clinics and research in hepatology and gastroenterology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Eosinophilic gastrointestinal diseases.Nature reviews. Disease primers · 2026
    Review
  2. Eosinophilic gastroduodenitis: a pediatric perspective.Italian journal of pediatrics · 2025
    Review
  3. Lessons learned: telehealth for patients with eosinophilic gastrointestinal diseases.Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus · 2025
    Article
  4. [Research progress on risk factors for poor prognosis in pediatric non-esophageal eosinophilic gastrointestinal disorder].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2025
    Review
  5. Segmental overlap is common in eosinophilic gastrointestinal diseases and impacts clinical presentation and treatment.Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus · 2025
    Article
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Elizabeth T JensenDepartment of Epidemiology and Prevention, Wake Forest University School of Medicine, Winston-Salem, NC, USA; Center for Gastrointestinal Biology and Disease, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
Xiangfeng DaiCenter for Gastrointestinal Biology and Disease, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
Ellyn KodroffCampaign Urging Research for Eosinophilic Disease (CURED), USA.
Mary Jo StrobelAmerican Partnership for Eosinophilic Disorders (APFED), USA.
Amy ZicarelliEosinophilic Family Coalition (EFC), USA.
Sarah GrayAusEE Inc, Australia.
Amanda CordellEOS Network, England.
Chelsea AndersonCenter for Gastrointestinal Biology and Disease, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
Girish HiremathDivision of Pediatric Gastroenterology, Hepatology, and Nutrition, Monroe Carell Jr. Children's Hospital at Vanderbilt, Vanderbilt University Medical Center, Nashville, TN, USA.
Evan S DellonCenter for Gastrointestinal Biology and Disease, University of North Carolina School of Medicine, Chapel Hill, NC, USA; Center for Esophageal Diseases and Swallowing, Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA. Electronic address: edellon@med.unc.edu.
University of North Carolina at Chapel Hill · USAmerican Partnership for Eosinophilic Disorders · USMonroe Carell Jr. Children's Hospital · US

Funding

UNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Hazel B Nichols · 2001 to 2026
$36.3M
PILOT AND FEASIBILITY STUDIESP30DK034987 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ROBERT S. SANDLER · 1985 to 2026
$30.5M
NIDDK NIH HHS P30 DK034987NIEHS NIH HHS P30 ES010126
6 · The paper itself

Abstract

objectivesEarly life exposures increase risk of eosinophilic esophagitis (EoE), but it is unknown whether they contribute to increased risk for non-EoE eosinophilic gastrointestinal diseases (EGIDs). We aimed to assess the association between prenatal, antenatal, and early life factors and non-EoE EGIDs.

methodsWe conducted a case-control study based in EGID Partners, an online patient-centered research network. Adults (≥18 years) with non-EoE EGIDs, caregivers of children <18 years of age with an EGID, and non-EGID adult controls were eligible. Subjects completed our Early Life Exposure Questionnaire, detailing maternal and early childhood exposures. We assessed for associations between non-EoE EGIDs and early life exposures, focusing on exposures previously evaluated in association with EoE.

resultsWe analyzed 61 non-EoE EGID cases and 20 controls. Of the EGID cases, 14 had eosinophilic gastritis, 19 had eosinophilic enteritis, 6 had eosinophilic colitis, and 22 had multiple areas affected; additionally, 30 had esophageal involvement. Relative to controls, EGID cases were more likely to have had antenatal/perinatal pregnancy-related complications (43% vs 13%; p = 0.02), NICU admission (20% vs 0%; p = 0.03), and antibiotics in infancy (43% vs 10%; p = 0.01). With adjustment for age at diagnosis, we observed increased odds of an EGID for pregnancy complications (aOR 3.83; 95% CI: 0.99-14.9) and antibiotic use in infancy (aOR 7.65; 95% CI: 1.28-45.7).

conclusionsEarly life factors, including pregnancy complications, NICU admission, and antibiotics in infancy, were associated with development of non-EoE EGIDs. The impact of early life exposures on non-EoE EGID pathogenic mechanisms should be investigated.

Indexed as

EnteritisEosinophilic EsophagitisGastritisPregnancy ComplicationsAdultAnti-Bacterial AgentsCase-Control StudiesChildChild, PreschoolEosinophiliaFemaleHumansPregnancyRisk FactorsAnti-Bacterial AgentsAntibioticsEarly life exposuresEosinophilic gastrointestinal diseasesNeonatal intensive care unitPregnancy complicationsRisk factors

Identifiers

PMID37352927
PMCPMC10529369
OpenAlexW4381480432

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.